TWA
RCKT icon

TCI Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

TCI Wealth Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-332
Closed -$5.69K – 1758
2023
Q1 		$5.69K Hold
332
– – ﹤0.01% 1439
2022
Q4 		$6.5K Hold
332
– – ﹤0.01% 1358
2022
Q3 		$5K Hold
332
– – ﹤0.01% 1508
2022
Q2 		$5K Buy
+332
New +$3.96K ﹤0.01% 1525
2021
Q4 		– Sell
-122
Closed -$4K – 2478
2021
Q3 		$4K Sell
122
-125
-51% -$4.55K ﹤0.01% 1805
2021
Q2 		$11K Buy
247
+186
+305% +$8.08K ﹤0.01% 920
2021
Q1 		$3K Buy
+61
New +$3.35K ﹤0.01% 1573

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

TCI Wealth Advisors's RCKT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q2 2023, closing a stake of 332 shares — an estimated $5.69K sold.

TCI Wealth Advisors first reported a position in RCKT in Q1 2021 and held it in 7 quarters. The position peaked at $11K in Q2 2021. 164 funds tracked by Wall St. Rank hold RCKT as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Rocket Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 332 Rocket Pharmaceuticals shares in Q2 2023, an estimated $5.69K.
  • TCI Wealth Advisors first reported a position in Rocket Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • TCI Wealth Advisors's Rocket Pharmaceuticals position peaked at $11K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.